動物用生物製剤の世界市場レポート 2024年

動物用生物製剤の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.6%の年間複合成長率（CAGR）で171億1,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、新興感染症の増加、気候変動の影響による疾病パターンの変化、精密畜産の進歩、総合的なOne Healthアプローチの採用、感染症の増加傾向など、いくつかの要因と結びついている可能性があります。ペットの所有権。この期間に予想される主要動向には、教育と研修プログラム、環境に優しく持続可能な生物学的製剤の開発、デジタル医療記録の統合、コンパニオンアニマル用生物学的製剤の急増、カスタマイズ型標的療法の普及などが含まれます。

動物の病気の蔓延の急増は、動物用生物製剤市場の成長の原動力になると予想されます。動物の病気には、多様な動物種に影響を及ぼすさまざまな病気が含まれます。これらの病気の増加は、高度な診断と治療ソリューションの必要性を浮き彫りにしており、動物の病気に対処し管理するために免疫学的な方法を採用する動物用生物製剤によってその需要が満たされます。 2022年10月の時点で、欧州疾病予防管理センターは、家禽における鳥インフルエンザの発生が2,467件報告され、4,800万羽の鳥に影響を及ぼし、さらに187件の症例が飼育されている鳥で観察されたと報告しました。これに関連して、世界保健機関は2022年 7月に、狂犬病により150か国以上で毎年 5万9,000人の命が奪われ、症例の大半がアフリカとアジアに集中していると発表しました。この動物の病気の急増は、動物用生物製剤市場を推進する極めて重要な要因です。

ペットの養子縁組の増加傾向は、動物用生物製剤市場の成長に大きく貢献する見込みです。ペットの養子縁組には、飼いならされた動物に対して、多くの場合、保護施設や保護団体から責任を負い、永続的な世話をする家を提供することが含まれます。 動物用生物製剤は、ペットの感染症の予防、免疫の提供、人獣共通感染症の制御、寿命と生活の質の向上、獣医療費の削減、ペットの生殖に関する健康の改善、より的を絞ったカスタマイズ型治療オプションの提供において重要な役割を果たします。米国ペット製品協会が報告した2023年10月のデータによると、米国の世帯の66％（合計8,690万）がペットを所有しており、その割合は2022年の62％から増加しています。このペットの導入の急増が、ペットの飼育拡大の大きな原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の動物用生物製剤市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の動物用生物製剤の市場規模実績と成長、2018～2023年
• 世界の動物用生物製剤市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の動物用生物製剤市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• ワクチン
• 診断キット
• 免疫調節剤
• 抗血清と抗体
• その他
• 世界の動物用生物製剤市場、疾患別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• ブルータング
• 口蹄疫
• ブルセラ症と結核
• その他
• 世界の動物用生物製剤市場、流通チャネル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 動物病院
• 動物クリニック
• その他
• 世界の動物用生物製剤市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 生産動物
• コンパニオンアニマル

第7章 地域と国の分析

• 世界の動物用生物製剤市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の動物用生物製剤市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物用生物製剤市場の競合情勢
• 動物用生物製剤市場の企業プロファイル
  • Bayer AG
  • Eli Lilly &Company
  • Evonik Industries AG
  • Zoetis Inc.
  • VCA Inc.

第31章 その他の大手と革新的な企業

• Merck Animal Health Inc.
• Boehringer Ingelheim Animal Health Inc.
• Elanco Animal Health
• IDEXX Laboratories Inc.
• Nutreco NV
• Virbac SA
• Hologic Inc.
• Phibro Animal Health Corporation
• Vetoquinol
• Valneva
• Abaxis Inc.
• Bimeda Biologicals
• Ceva Sante Animale SA
• Heska Corporation
• Heska Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Veterinary biologics encompass biological products obtained from living organisms such as viruses, bacteria, or other microorganisms. These specialized products in veterinary medicine serve to prevent, diagnose, or treat diseases in animals.

Key products falling under veterinary biologics include vaccines, diagnostic kits, immunomodulators, antiserums, antibodies, and related items. Vaccines, for instance, are formulated to trigger the immune system's response and offer protection against specific animal diseases. They address various ailments such as bluetongue, foot and mouth disease, brucellosis, tuberculosis, and others. These products are distributed through multiple channels, including veterinary hospitals and clinics, for diverse applications involving both production and companion animals.

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides veterinary biologics market statistics, including veterinary biologics industry global market size, regional shares, competitors with a veterinary biologics market share, detailed veterinary biologics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. This veterinary biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biologics market size has grown strongly in recent years. It will grow from $11.77 billion in 2023 to $12.78 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historic period can be linked to several factors. These include occurrences of animal disease outbreaks, supportive regulatory frameworks and standards, an increasing emphasis on food safety, the globalization of trade, and the substantial economic importance placed on livestock.

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $17.11 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in the forecast period can be tied to several factors, including the rise of emerging infectious diseases, changing disease patterns influenced by climate change, advancements in precision livestock farming, the adoption of a holistic One Health approach, and the increasing trend of pet ownership. Key trends expected in this period encompass education and training programs, the development of eco-friendly and sustainable biologics, integration of digital health records, a surge in companion animal biologics, and the proliferation of customized and targeted therapies.

The upsurge in the prevalence of animal diseases is anticipated to be a driving force behind the growth of the veterinary biologics market. Animal diseases encompass a range of illnesses affecting diverse animal species. The escalation in these diseases underscores the need for advanced diagnostic and treatment solutions, a demand met by veterinary biologics that employ immunological methods to address and manage animal diseases. As of October 2022, the European Center for Disease Prevention and Control reported 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds, with an additional 187 cases observed in captive birds. In a related context, the World Health Organization disclosed in July 2022 that rabies claims the lives of 59,000 people annually across over 150 countries, with a predominant 95% of cases concentrated in Africa and Asia. This surge in animal diseases is a pivotal factor propelling the veterinary biologics market.

The increasing trend of pet adoption is poised to contribute significantly to the growth of the veterinary biologics market. Pet adoption involves assuming responsibility for a domesticated animal, often from shelters or rescue organizations, to provide a permanent and caring home. Veterinary biologics play a crucial role in preventing infectious diseases in pets, offering immunity, controlling zoonotic diseases, enhancing lifespan and quality of life, reducing veterinary healthcare costs, improving reproductive health in pets, and providing more targeted and customized treatment options. Data from October 2023, as reported by the American Pet Products Association, reveals that 66% of U.S. households, totaling 86.9 million, own a pet-an increase from 62% in 2022. This surge in pet adoption is a significant driver behind the expanding veterinary biologics market.

The trend of developing innovative biologics is gaining momentum in the veterinary biologics market, with major companies spearheading efforts in this direction. In March 2021, Elanco Animal Health Incorporated, a prominent U.S.-based veterinary pharmaceutical company, introduced Elura (capromorelin oral solution) to address weight loss in cats afflicted with chronic kidney diseases (CKD). Notably, Elura represents the inaugural ghrelin receptor agonist sanctioned by the U.S. Food and Drug Administration (FDA), utilizing a novel mechanism to combat weight loss in cats with CKD. This oral solution, characterized by a palatable taste and a minimal dosage, serves as a long-term treatment option introduced at the time of diagnosis, supporting cat owners in managing their animals through this ailment.

Companies at the forefront of the veterinary biologics market are also channeling their efforts into the creation of innovative products, such as injections designed to control pain associated with osteoarthritis (OA) in dogs. These injections target canine nerve growth factors, providing an effective means to alleviate the pain that dogs experience due to osteoarthritis. Zoetis Inc., a distinguished U.S.-based animal health company, secured approval from the U.S. Food and Drug Administration (FDA) for Librela (bedinvetmab injection) in May 2023. Positioned as the first and only monthly anti-NGF monoclonal antibody medication for canine OA pain, Librela stands out as a safe and efficacious solution for managing long-term OA pain symptoms in dogs. This approval underscores Librela's role in enhancing the mobility and overall well-being of canines grappling with osteoarthritis, contributing to an improved quality of life for these animals.

In August 2021, Elanco Animal Health Incorporated, a US-based animal health company, completed the acquisition of Kindred Biosciences for approximately $444 million. Through this strategic acquisition, Elanco aimed to strengthen its position in the dermatology market within the veterinary medicine sector. This acquisition enabled Elanco to not only cater more effectively to its current customer base but also expand its reach by attracting new clients. Kindred Biosciences, the acquired company, specializes in the development of biologics and advanced technologies for veterinary medicine.

Major companies operating in the veterinary biologics market report are Bayer AG, Eli Lilly & Company,Evonik Industries AG, Zoetis Inc., VCA Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Nutreco N.V., Virbac SA, Hologic Inc., Phibro Animal Health Corporation, Vetoquinol, Valneva, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd.,FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

North America was the largest region in the veterinary biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Vaccines; Diagnostic Kits; Immunomodulators; Antiserums And Antibodies; Other Products
• 2) By Disease Type: Bluetongue; Foot And Mouth Disease; Brucellosis And Tuberculosis; Other Diseases
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Other Distribution Channels
• 4) By Application: Production Animal; Companion Animal
• Companies Mentioned: Bayer AG; Eli Lilly & Company;Evonik Industries AG; Zoetis Inc.; VCA Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Biologics Market Characteristics

3. Veterinary Biologics Market Trends And Strategies

4. Veterinary Biologics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Veterinary Biologics Market Size and Growth

• 5.1. Global Veterinary Biologics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Veterinary Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Veterinary Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Biologics Market Segmentation

• 6.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Vaccines
• Diagnostic Kits
• Immunomodulators
• Antiserums And Antibodies
• Other Products
• 6.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bluetongue
• Foot And Mouth Disease
• Brucellosis And Tuberculosis
• Other Diseases
• 6.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Other Distribution Channels
• 6.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Production Animal
• Companion Animal

7. Veterinary Biologics Market Regional And Country Analysis

• 7.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Biologics Market

• 8.1. Asia-Pacific Veterinary Biologics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Biologics Market

• 9.1. China Veterinary Biologics Market Overview
• 9.2. China Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Biologics Market

• 10.1. India Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Biologics Market

• 11.1. Japan Veterinary Biologics Market Overview
• 11.2. Japan Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Biologics Market

• 12.1. Australia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Biologics Market

• 13.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Biologics Market

• 14.1. South Korea Veterinary Biologics Market Overview
• 14.2. South Korea Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Biologics Market

• 15.1. Western Europe Veterinary Biologics Market Overview
• 15.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Biologics Market

• 16.1. UK Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Biologics Market

• 17.1. Germany Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Biologics Market

• 18.1. France Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Biologics Market

• 19.1. Italy Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Biologics Market

• 20.1. Spain Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Biologics Market

• 21.1. Eastern Europe Veterinary Biologics Market Overview
• 21.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Biologics Market

• 22.1. Russia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Biologics Market

• 23.1. North America Veterinary Biologics Market Overview
• 23.2. North America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Biologics Market

• 24.1. USA Veterinary Biologics Market Overview
• 24.2. USA Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Biologics Market

• 25.1. Canada Veterinary Biologics Market Overview
• 25.2. Canada Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Biologics Market

• 26.1. South America Veterinary Biologics Market Overview
• 26.2. South America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Biologics Market

• 27.1. Brazil Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Biologics Market

• 28.1. Middle East Veterinary Biologics Market Overview
• 28.2. Middle East Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Biologics Market

• 29.1. Africa Veterinary Biologics Market Overview
• 29.2. Africa Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Biologics Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Biologics Market Competitive Landscape
• 30.2. Veterinary Biologics Market Company Profiles
  • 30.2.1. Bayer AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Eli Lilly & Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Evonik Industries AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Zoetis Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. VCA Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Veterinary Biologics Market Other Major And Innovative Companies

• 31.1. Merck Animal Health Inc.
• 31.2. Boehringer Ingelheim Animal Health Inc.
• 31.3. Elanco Animal Health
• 31.4. IDEXX Laboratories Inc.
• 31.5. Nutreco N.V.
• 31.6. Virbac SA
• 31.7. Hologic Inc.
• 31.8. Phibro Animal Health Corporation
• 31.9. Vetoquinol
• 31.10. Valneva
• 31.11. Abaxis Inc.
• 31.12. Bimeda Biologicals
• 31.13. Ceva Sante Animale S.A.
• 31.14. Heska Corporation
• 31.15. Heska Corporation

32. Global Veterinary Biologics Market Competitive Benchmarking

33. Global Veterinary Biologics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Biologics Market

35. Veterinary Biologics Market Future Outlook and Potential Analysis

• 35.1 Veterinary Biologics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Veterinary Biologics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Veterinary Biologics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer